This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Aska Pharmaceutical Co., Ltd.. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Yukinao Yamauchi: Pioneer in Pyrimidine Derivatives
Introduction
Yukinao Yamauchi is an innovative inventor based in Kawasaki, Japan, known for his groundbreaking work in the field of medicinal chemistry. His research focuses on creating therapeutic solutions for a range of diseases, offering significant advancements in patient care.
Latest Patents
Yamauchi holds a patent for pyrimidine derivatives, which are represented by a specific formula. This invention showcases compounds that exhibit both 5-HT agonistic and 5-HT antagonistic activities. The ability of these derivatives to provide synergistic effects makes them particularly useful in the therapy and treatment of conditions such as Irritable Bowel Syndrome (IBS). His invention also outlines a novel therapeutic method for IBS, where the simultaneous and cooperative action of these activities can be harnessed to enhance treatment efficacy.
Career Highlights
Currently, Yukinao Yamauchi is associated with Aska Pharmaceutical Co., Ltd., where he contributes to the development of innovative therapies. His work is marked by a commitment to improving patient outcomes through scientific advancement.
Collaborations
Throughout his career, Yamauchi has collaborated with notable colleagues, including Michitaka Sato and Teruaki Matsui. These partnerships reflect a strong network of innovation and teamwork that drives success in research and development.
Conclusion
Yukinao Yamauchi is making significant strides in the field of pharmaceuticals with his invention of pyrimidine derivatives. His dedication to innovation and collaboration is paving the way for improved therapeutic options, particularly for conditions like IBS. As he continues his work at Aska Pharmaceutical Co., Ltd., the potential of his inventions promises to enhance the quality of care in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile